nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—ABCB1—Mitomycin—urinary bladder cancer	0.263	0.379	CbGbCtD
Mebendazole—CYP3A4—Thiotepa—urinary bladder cancer	0.119	0.172	CbGbCtD
Mebendazole—ABCB1—Gemcitabine—urinary bladder cancer	0.0756	0.109	CbGbCtD
Mebendazole—ABCB1—Cisplatin—urinary bladder cancer	0.055	0.0792	CbGbCtD
Mebendazole—ABCB1—Etoposide—urinary bladder cancer	0.054	0.0778	CbGbCtD
Mebendazole—ABCB1—Doxorubicin—urinary bladder cancer	0.0368	0.0531	CbGbCtD
Mebendazole—ABCB1—Methotrexate—urinary bladder cancer	0.0357	0.0514	CbGbCtD
Mebendazole—CYP3A4—Etoposide—urinary bladder cancer	0.0324	0.0466	CbGbCtD
Mebendazole—CYP3A4—Doxorubicin—urinary bladder cancer	0.0221	0.0318	CbGbCtD
Mebendazole—TUBA1A—prostate gland—urinary bladder cancer	0.0117	0.0774	CbGeAlD
Mebendazole—TUBA1A—Zalcitabine—Gemcitabine—urinary bladder cancer	0.0114	0.826	CbGdCrCtD
Mebendazole—TUBA1A—seminal vesicle—urinary bladder cancer	0.00987	0.0655	CbGeAlD
Mebendazole—CYP3A4—urine—urinary bladder cancer	0.0089	0.0591	CbGeAlD
Mebendazole—TUBA1A—epithelium—urinary bladder cancer	0.00858	0.0569	CbGeAlD
Mebendazole—TUBA1A—smooth muscle tissue—urinary bladder cancer	0.00826	0.0548	CbGeAlD
Mebendazole—TUBA1A—renal system—urinary bladder cancer	0.00795	0.0528	CbGeAlD
Mebendazole—TUBA1A—urethra—urinary bladder cancer	0.00781	0.0518	CbGeAlD
Mebendazole—TUBB4B—prostate gland—urinary bladder cancer	0.00778	0.0516	CbGeAlD
Mebendazole—TUBB4B—seminal vesicle—urinary bladder cancer	0.00658	0.0436	CbGeAlD
Mebendazole—TUBA1A—female reproductive system—urinary bladder cancer	0.00637	0.0423	CbGeAlD
Mebendazole—TUBA1A—vagina—urinary bladder cancer	0.00576	0.0382	CbGeAlD
Mebendazole—TUBB4B—smooth muscle tissue—urinary bladder cancer	0.00551	0.0365	CbGeAlD
Mebendazole—TUBB4B—renal system—urinary bladder cancer	0.0053	0.0352	CbGeAlD
Mebendazole—TUBB4B—urethra—urinary bladder cancer	0.00521	0.0345	CbGeAlD
Mebendazole—TUBB4B—female reproductive system—urinary bladder cancer	0.00425	0.0282	CbGeAlD
Mebendazole—TUBB4B—vagina—urinary bladder cancer	0.00384	0.0255	CbGeAlD
Mebendazole—TUBA1A—lymph node—urinary bladder cancer	0.00373	0.0247	CbGeAlD
Mebendazole—CYP1A1—epithelium—urinary bladder cancer	0.0032	0.0212	CbGeAlD
Mebendazole—CYP1A1—renal system—urinary bladder cancer	0.00297	0.0197	CbGeAlD
Mebendazole—CYP1A1—urethra—urinary bladder cancer	0.00292	0.0193	CbGeAlD
Mebendazole—TUBB4B—lymph node—urinary bladder cancer	0.00248	0.0165	CbGeAlD
Mebendazole—Ketoprofen—CXCL8—urinary bladder cancer	0.00248	0.271	CrCbGaD
Mebendazole—TUBA1A—Azacitidine—Gemcitabine—urinary bladder cancer	0.00241	0.174	CbGdCrCtD
Mebendazole—CYP1A1—female reproductive system—urinary bladder cancer	0.00238	0.0158	CbGeAlD
Mebendazole—Ketorolac—PTGS2—urinary bladder cancer	0.0023	0.251	CrCbGaD
Mebendazole—ABCB1—prostate gland—urinary bladder cancer	0.00226	0.015	CbGeAlD
Mebendazole—CYP3A4—renal system—urinary bladder cancer	0.00218	0.0144	CbGeAlD
Mebendazole—CYP1A1—vagina—urinary bladder cancer	0.00215	0.0143	CbGeAlD
Mebendazole—ABCB1—seminal vesicle—urinary bladder cancer	0.00191	0.0127	CbGeAlD
Mebendazole—Tiaprofenic acid—PTGS2—urinary bladder cancer	0.00188	0.205	CrCbGaD
Mebendazole—Nepafenac—PTGS2—urinary bladder cancer	0.00179	0.195	CrCbGaD
Mebendazole—CYP3A4—female reproductive system—urinary bladder cancer	0.00174	0.0116	CbGeAlD
Mebendazole—ABCB1—epithelium—urinary bladder cancer	0.00166	0.011	CbGeAlD
Mebendazole—ABCB1—renal system—urinary bladder cancer	0.00154	0.0102	CbGeAlD
Mebendazole—ABCB1—urethra—urinary bladder cancer	0.00151	0.01	CbGeAlD
Mebendazole—CYP1A1—lymph node—urinary bladder cancer	0.00139	0.00923	CbGeAlD
Mebendazole—ABCB1—female reproductive system—urinary bladder cancer	0.00123	0.00819	CbGeAlD
Mebendazole—ABCB1—vagina—urinary bladder cancer	0.00112	0.00741	CbGeAlD
Mebendazole—Ketoprofen—PTGS2—urinary bladder cancer	0.000724	0.0789	CrCbGaD
Mebendazole—ABCB1—lymph node—urinary bladder cancer	0.000722	0.00479	CbGeAlD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000588	0.00444	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—EP300—urinary bladder cancer	0.000587	0.00443	CbGpPWpGaD
Mebendazole—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000586	0.00442	CbGpPWpGaD
Mebendazole—TUBB4B—Orphan transporters—CREBBP—urinary bladder cancer	0.000564	0.00426	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—SMC1A—urinary bladder cancer	0.000537	0.00405	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000537	0.00405	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000535	0.00404	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.000527	0.00398	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	0.000518	0.00391	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.000518	0.00391	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000484	0.00366	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.00047	0.00355	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CDX2—urinary bladder cancer	0.000466	0.00352	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—STAG2—urinary bladder cancer	0.000463	0.0035	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—LIG1—urinary bladder cancer	0.000463	0.0035	CbGpPWpGaD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000437	0.0033	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000436	0.00329	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	0.000426	0.00322	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—NAT2—urinary bladder cancer	0.000422	0.00319	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000416	0.00314	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000416	0.00314	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000411	0.0031	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000409	0.00309	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.0004	0.00302	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000394	0.00298	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RRM2—urinary bladder cancer	0.000381	0.00288	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000379	0.00286	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000379	0.00286	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000374	0.00282	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCNE1—urinary bladder cancer	0.000372	0.00281	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TYMS—urinary bladder cancer	0.000365	0.00276	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.000363	0.00274	CbGpPWpGaD
Mebendazole—TUBB4B—G2/M Transition—EP300—urinary bladder cancer	0.00036	0.00271	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—EP300—urinary bladder cancer	0.000355	0.00268	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000347	0.00262	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000342	0.00258	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000338	0.00255	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—HPGDS—urinary bladder cancer	0.000338	0.00255	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTT1—urinary bladder cancer	0.000327	0.00247	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000325	0.00245	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—SMC1A—urinary bladder cancer	0.000324	0.00245	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	0.000319	0.00241	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TERT—urinary bladder cancer	0.000318	0.0024	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000316	0.00238	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000316	0.00238	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000313	0.00236	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000312	0.00236	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000308	0.00232	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—NCOR1—urinary bladder cancer	0.000298	0.00225	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000295	0.00223	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000294	0.00222	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000293	0.00221	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.000292	0.0022	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—ATM—urinary bladder cancer	0.000286	0.00216	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDK4—urinary bladder cancer	0.000285	0.00215	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000281	0.00212	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000281	0.00212	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000278	0.0021	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—RB1—urinary bladder cancer	0.000277	0.00209	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000273	0.00206	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000273	0.00206	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000269	0.00203	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000251	0.0019	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000248	0.00187	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RB1—urinary bladder cancer	0.000248	0.00187	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000247	0.00186	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000247	0.00186	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000246	0.00186	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000245	0.00185	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000244	0.00184	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	0.000244	0.00184	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000239	0.00181	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000239	0.00181	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000228	0.00172	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000228	0.00172	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000227	0.00171	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000226	0.00171	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCNE1—urinary bladder cancer	0.000225	0.0017	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000225	0.0017	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000224	0.00169	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TYMS—urinary bladder cancer	0.000221	0.00167	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2A—urinary bladder cancer	0.000218	0.00164	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000214	0.00161	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000209	0.00158	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000209	0.00157	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000208	0.00157	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	0.000206	0.00155	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000206	0.00155	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000205	0.00155	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000205	0.00155	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—IGF1—urinary bladder cancer	0.000205	0.00155	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000201	0.00152	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.000201	0.00152	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	0.000199	0.0015	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000198	0.0015	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	0.000192	0.00145	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TERT—urinary bladder cancer	0.000192	0.00145	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000192	0.00145	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—EP300—urinary bladder cancer	0.000189	0.00143	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000186	0.0014	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND1—urinary bladder cancer	0.000184	0.00139	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN1A—urinary bladder cancer	0.000178	0.00134	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—ATM—urinary bladder cancer	0.000173	0.0013	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDK4—urinary bladder cancer	0.000172	0.0013	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.00017	0.00128	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—EP300—urinary bladder cancer	0.000169	0.00128	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000168	0.00127	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RB1—urinary bladder cancer	0.000167	0.00126	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000166	0.00125	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	0.000165	0.00125	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000165	0.00124	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000162	0.00123	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000162	0.00122	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000161	0.00122	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000158	0.00119	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000155	0.00117	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RB1—urinary bladder cancer	0.00015	0.00113	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYC—urinary bladder cancer	0.000148	0.00111	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	0.000147	0.00111	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.000144	0.00109	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—EP300—urinary bladder cancer	0.00014	0.00106	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	0.000139	0.00105	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000138	0.00104	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000138	0.00104	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000137	0.00104	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000137	0.00103	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000132	0.001	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NAT1—urinary bladder cancer	0.000132	0.000995	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	0.000132	0.000995	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—urinary bladder cancer	0.000132	0.000993	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00013	0.000978	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	0.000124	0.000938	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGF1—urinary bladder cancer	0.000124	0.000933	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000121	0.000916	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—urinary bladder cancer	0.000121	0.000915	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000121	0.000912	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	0.000121	0.00091	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.00012	0.000908	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	0.00012	0.000908	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	0.000118	0.000892	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—EP300—urinary bladder cancer	0.000114	0.000864	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000112	0.000843	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND1—urinary bladder cancer	0.000111	0.000839	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	0.000111	0.000838	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00011	0.000831	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	0.000109	0.000819	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1A—urinary bladder cancer	0.000108	0.000811	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000105	0.000796	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTO2—urinary bladder cancer	0.000105	0.000794	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NAT1—urinary bladder cancer	0.000105	0.000794	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000104	0.000786	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000103	0.000775	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	0.000102	0.000774	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—EP300—urinary bladder cancer	0.000102	0.000772	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000101	0.000764	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	9.99e-05	0.000754	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—urinary bladder cancer	9.97e-05	0.000753	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CXCL8—urinary bladder cancer	9.94e-05	0.000751	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	9.63e-05	0.000727	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	9.43e-05	0.000712	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.95e-05	0.000675	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—urinary bladder cancer	8.91e-05	0.000673	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	8.83e-05	0.000667	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	8.67e-05	0.000654	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	8.63e-05	0.000652	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	8.18e-05	0.000618	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.01e-05	0.000604	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TYMP—urinary bladder cancer	7.98e-05	0.000603	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PRSS3—urinary bladder cancer	7.98e-05	0.000602	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	7.8e-05	0.000589	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.67e-05	0.000579	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	7.55e-05	0.00057	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	7.53e-05	0.000568	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—urinary bladder cancer	7.32e-05	0.000553	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NAT2—urinary bladder cancer	7.22e-05	0.000545	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.18e-05	0.000542	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.98e-05	0.000527	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.84e-05	0.000516	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.48e-05	0.000489	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.48e-05	0.000489	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TYMP—urinary bladder cancer	6.38e-05	0.000481	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.26e-05	0.000472	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—RRM2—urinary bladder cancer	6.23e-05	0.00047	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.12e-05	0.000462	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.93e-05	0.000448	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.83e-05	0.00044	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.78e-05	0.000436	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ENO2—urinary bladder cancer	5.77e-05	0.000436	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	5.77e-05	0.000436	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NAT2—urinary bladder cancer	5.77e-05	0.000435	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.74e-05	0.000433	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	5.6e-05	0.000423	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.51e-05	0.000416	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.34e-05	0.000403	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.14e-05	0.000388	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.04e-05	0.000381	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.98e-05	0.000376	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.91e-05	0.000371	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NQO1—urinary bladder cancer	4.65e-05	0.000351	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.61e-05	0.000348	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.61e-05	0.000348	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.51e-05	0.000341	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTT1—urinary bladder cancer	4.47e-05	0.000338	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.19e-05	0.000316	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.94e-05	0.000297	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.93e-05	0.000297	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	3.88e-05	0.000293	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.75e-05	0.000283	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.72e-05	0.000281	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TYMS—urinary bladder cancer	3.61e-05	0.000272	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	3.57e-05	0.000269	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	3.57e-05	0.000269	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.55e-05	0.000268	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GPX1—urinary bladder cancer	3.41e-05	0.000258	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	3.35e-05	0.000253	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	3.15e-05	0.000238	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTP1—urinary bladder cancer	3.1e-05	0.000234	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.07e-05	0.000232	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.88e-05	0.000218	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.85e-05	0.000215	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.85e-05	0.000215	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.84e-05	0.000214	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.84e-05	0.000214	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.75e-05	0.000208	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.73e-05	0.000206	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.68e-05	0.000202	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARG—urinary bladder cancer	2.56e-05	0.000193	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.52e-05	0.00019	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	2.45e-05	0.000185	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.29e-05	0.000173	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.04e-05	0.000154	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	2.01e-05	0.000152	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.96e-05	0.000148	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.91e-05	0.000144	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.78e-05	0.000134	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.75e-05	0.000132	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.75e-05	0.000132	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTEN—urinary bladder cancer	1.75e-05	0.000132	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.68e-05	0.000127	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—EP300—urinary bladder cancer	1.67e-05	0.000126	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.65e-05	0.000125	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.61e-05	0.000121	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.55e-05	0.000117	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.4e-05	0.000106	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—EP300—urinary bladder cancer	1.34e-05	0.000101	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.26e-05	9.49e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.21e-05	9.12e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.89e-06	7.47e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.63e-06	6.51e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.23e-06	6.21e-05	CbGpPWpGaD
